The MOU sets out a framework for the collaborative partnership between MED and USI to develop and produce Head Mounted Display (HMD) modules incorporating the eyescreen^TM microdisplay from MED. Under the agreement USI will assemble complete display modules, which will be offered as a turnkey solution to the major players in the global HMD market.

Commenting on the agreement, MED Chief Executive, Bill Miller said, “This MOU represents another important step forward for MED and illustrates the traction we are enjoying with potential partners and customers. The performance capabilities and low power demands of the eyescreen^TM differentiate our product from the incumbent technologies currently servicing the HMD market. We are delighted to be partnering with a global player in USI and look forward to working with them to produce a world-class module.”

The P-OLED eyescreen^TM from MED offers exceptional image quality without the need of backlighting, this along with its size and power efficiency enables it to be directly attached to the HMD bridge thereby reducing manufacturing complexity.

About MicroEmissive Displays
MicroEmissive Displays (MED - AIM, London Stock Exchange) is a leader in polymer organic light emitting diode (P-OLED) microdisplay technology. The company was founded in 1999 and has developed a unique emissive microdisplay technology by using a P-OLED layer on a CMOS substrate. In late 2004, MicroEmissive Displays floated on the Alternative Investment Market of the London Stock Exchange (AIM) and the first product release and commercial shipments of MicroEmissive Displays’ eyescreen^TM microdisplays were made in 2005. The company held the official opening of its volume manufacturing facility in Dresden, Germany in May 2007.

MicroEmissive Displays has been awarded ISO 9001:2000 registration for the research, design, development, marketing and manufacturing of digital microdisplay solutions and is working towards full accreditation in 2008. MicroEmissive Displays is headquartered at the Scottish Microelectronics Centre, Edinburgh, Scotland and its manufacturing site is in Dresden, Germany. The company employs more than 70 people and also has sales representatives and applications support located in Asia, the USA and Europe.

About eyescreen^TM
MicroEmissive Displays’ eyescreen^TM products are the world’s only polymer organic light emitting diode (P-OLED) microdisplays. The full colour eyescreen^TM combines superb TV quality moving video images that are free from flicker, with ultra-low power consumption, enabling greatly extended battery life for the consumer. This enhancement in battery usage time made possible by the eyescreen^TM will play a vital role in the widespread adoption of portable head-sets for personal TV and video viewing in the consumer marketplace. The innovative design of the eyescreen^TM, with its integrated driver ICs and its digital interface, offers product design engineers a fast, robust design-in solution for smaller, lighter-weight, stylish products of the future, all for a size comparable with the pupil of the human eye.

Awards
Finalist at the Elektra Awards 2007 in the Research and Development category
Short-listed for the Best of British Industry Awards 2006, Next Generation Award
Winner of IEE Innovation in Engineering Award 2005, Emerging Technologies Award
Winner Gannochy Medal 2004, Professor Ian Underwood - Scotland’s Top Innovator
Winner European Semiconductor Start-Up of the Year 2004
Listed in Tornado Insider’s Top 100 in 2003
Listed in Tornado Insider’s Top 100 in 2002

- ends -

For further information please contact:
Dr Natalie Polack, Product Marketing Manager, MicroEmissive Displays
Scottish Microelectronics Centre, West Mains Road, Edinburgh, EH9 3JF
Tel: + 44 (0) 131 650 7764; Fax: + 44 (0) 131 650 7761
E-mail: info@microemissive.com; Web: www.microemissive.com

Nicki Langley
Neesham Public Relations
Tel: +44 (0) 1506 670800
Email: nickil@neesham.co.uk

r0721me

Trading Update and Strategic Review

Further to the trading update on 13th May 2008 MED wishes to make the following announcement.

The Board continues to believe that the outlook for MEDs revolutionary eyescreen^TM display remains extremely positive, due to its strongly differentiated technology. MED continues to make progress with regard to its largest addressable market, high resolution electronic viewfinders for digital still cameras and camcorders. This market is currently estimated to be in excess of 20 million units annually and continues to grow. MED is in discussion with leading camera manufacturers in conjunction with its Japanese partner, KAGA, and believes that its technology has the potential to place MED in a strong competitive position.

The Company also continues to make good progress with regard to design-ins for eyescreen^TM in the head mounted display market. However, conversion of these designs into sales, and sales generally, has taken longer than anticipated and as a result of this, the Company is seeking to raise additional capital to strengthen its financial position.

In this regard the Board is reviewing its strategic options for the future financing of the Company, which may include considering proposals for an offer for the Company.

The Board will update the shareholders in due course.

Enquiries

Arbuthnot Securities
Neil Kirton / John Prior
Tel: 020 7012 2000

Tavistock Communications
Matt Ridsdale / Andrew Dunn
Tel: 020 7920 3150

In accordance with Rule 2.10 of the Code, MED confirms that it has in issue admitted to trading on the London Stock Exchange plc 59,352,206 ordinary shares of 1 pence each under the International Securities Identification Number GB00B0346S80.

Dealing Disclosure Requirements
Under the provisions of Rule 8.3 of the Takeover Code (the ‘Code’), if any person is, or becomes, ‘interested’ (directly or indirectly) in 1% or more of any class of ‘relevant securities’ of MED, all ‘dealings’ in any ‘relevant securities’ of that company (including by means of an option in respect of, or a derivative referenced to, any such ‘relevant securities’) must be publicly disclosed by no later than 3.30 p.m. (London time) on the London business day following the date of the relevant transaction. This requirement will continue until the date on which any offer (if made) becomes, or is declared, unconditional as to acceptances, lapses or is otherwise withdrawn or on which the ‘offer period’ otherwise ends. If two or more persons act together pursuant to an agreement or understanding, whether formal or informal, to acquire an ‘interest’ in ‘relevant securities’ of MED, they will be deemed to be a single person for the purpose of Rule 8.3.

Under the provisions of Rule 8.1 of the Code, all ‘dealings’ in ‘relevant securities’ of MED by MED, or by any of its ‘associates’, must be disclosed by no later than 12.00 noon (London time) on the London business day following the date of the relevant transaction.

A disclosure table, giving details of the companies in whose ‘relevant securities’ ‘dealings’ should be disclosed, and the number of such securities in issue, can be found on the Takeover Panel’s website at www.thetakeoverpanel.org.uk.

‘Interests in securities’ arise, in summary, when a person has long economic exposure, whether conditional or absolute, to changes in the price of securities. In particular, a person will be treated as having an ‘interest’ by virtue of the ownership or control of securities, or by virtue of any option in respect of or derivative referenced to, securities.

Terms in quotation marks are defined in the Code, which can also be found on the Panel’s website. If you are in any doubt as to whether or not you are required to disclose a ‘dealing’ under Rule 8, you should consult the Panel.

TR-1: Notifications of Major Interests in Shares
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:
MicroEmissive Displays Group plc

2. Reason for notification (yes/no)
An acquisition or disposal of voting rights: Yes
An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached:
An event changing the breakdown of voting rights:
Other (please specify):

3. Full name of person(s) subject to notification obligation:
Ironshield Capital Management LLP

4. Full name of shareholder(s) (if different from 3):
Ironshield Special Situations Master Fund LP

5. Date of transaction (and date on which the threshold is crossed or reached if different):
17 July 2008

6. Date on which issuer notified:
17 July 2008

7. Threshold(s) that is/are crossed or reached:
5.00%

8: Notified Details
A: Voting rights attached to shares

Class/type of shares
If possible use ISIN code
GB00B0346S80

Situation previous to the triggering transaction
Number of shares: 3,002,000
Number of voting rights 3,002,000

Resulting situation after the triggering transaction
Number of shares: 2,812,000
Number of voting rights: Direct, Indirect
Percentage of voting rights: Direct 4.74%, Indirect

B: Financial Instruments
Resulting situation after the triggering transaction
Type of financial instrument
Expiration date
Exercise/ conversion period/date
No. of voting rights that may be acquired (if the instrument exercised/converted)
Percentage of voting rights

Total (A+B)
Number of voting rights: 2,812,000
Percentage of voting rights: 4.74%

9. Chain of controlled undertakings through which the voting rights and /or the financial instruments are effectively held, if applicable:

Proxy Voting:
10. Name of proxy holder:

11. Number of voting rights proxy holder will cease to hold:

12. Date on which proxy holder will cease to hold voting rights:

13. Additional information:

14 Contact name:
Phillip Chapple

15. Contact telephone name:
+44 (0) 207 464 4223

END

According to the terms of the MOU, Kaga will provide sales and marketing support to the consumer electronics design community throughout Japan for MED’s microdisplay products. Additionally, Kaga will incorporate MED’s P-OLED microdisplay into its proprietary electronic viewfinder (EVF) modules to create new products for the Japanese digital camera market.

Commenting on the agreement, MED chief executive Bill Miller, said, “The agreement with Kaga represents a significant step forward for MED and a chance to showcase the considerable quality and power advantages of our P-OLED microdisplay in this technology hungry market. The EVF market in digital cameras is a significant opportunity for our product and we look forward to developing a strong relationship with a partner of the calibre and market presence of Kaga.”

The P-OLED microdisplay from MED provides a unique lightweight, low power display with distinct advantages over existing LCD technology. The device is ideally placed to exploit the opportunities in the growing EVF market, as it dispenses with inefficient and bulky backlighting resulting in a smaller more efficient module.

About MicroEmissive Displays
MicroEmissive Displays (MED - AIM, London Stock Exchange) is a leader in polymer organic light emitting diode (P-OLED) microdisplay technology. The company was founded in 1999 and has developed a unique emissive microdisplay technology by using a P-OLED layer on a CMOS substrate. In late 2004, MicroEmissive Displays floated on the Alternative Investment Market of the London Stock Exchange (AIM) and the first product release and commercial shipments of MicroEmissive Displays’ microdisplays were made in 2005. The company held the official opening of its volume manufacturing facility in Dresden, Germany in May 2007.

MicroEmissive Displays has been awarded ISO 9001:2000 registration for the research, design, development, marketing and manufacturing of digital microdisplay solutions and is working towards full accreditation in 2008. MicroEmissive Displays is headquartered at the Scottish Microelectronics Centre, Edinburgh, Scotland and its manufacturing site is in Dresden, Germany. The company employs more than 70 people and also has sales representatives and applications support located in Asia, the USA and Europe.

MicroEmissive Displays’ products are the world’s only polymer organic light emitting diode (P-OLED) microdisplays. The full colour P-OLED microdisplay combines superb TV quality moving video images that are free from flicker, with ultra-low power consumption, enabling greatly extended battery life for the consumer. This enhancement in battery usage time will play a vital role in the widespread adoption of portable head-sets for personal TV and video viewing in the consumer marketplace. The innovative design of the microdisplay, with its integrated driver ICs and its digital interface, offers product design engineers a fast, robust design-in solution for smaller, lighter-weight, stylish products of the future, all for a size comparable with the pupil of the human eye.

Awards
Finalist at the Elektra Awards 2007 in the Research and Development category
Short-listed for the Best of British Industry Awards 2006, Next Generation Award
Winner of IEE Innovation in Engineering Award 2005, Emerging Technologies Award
Winner Gannochy Medal 2004, Professor Ian Underwood - Scotland’s Top Innovator
Winner European Semiconductor Start-Up of the Year 2004
Listed in Tornado Insider’s Top 100 in 2003
Listed in Tornado Insider’s Top 100 in 2002

- ends -

For further information please contact:
Dr Natalie Polack, Product Marketing Manager, MicroEmissive Displays
Scottish Microelectronics Centre, West Mains Road, Edinburgh, EH9 3JF
Tel: + 44 (0) 131 650 7764; Fax: + 44 (0) 131 650 7761
E-mail: info@microemissive.com; Web: www.microemissive.com

Nicki Langley
Neesham Public Relations
Tel: +44 (0) 1506 670800
Email: nickil@neesham.co.uk

TR-1: notification of major interests in shares

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:
Microemissive Displays Plc

2. Reason for the notification (please tick the appropriate box or boxes)
An acquisition or disposal of voting rights
An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached
An event changing the breakdown of voting rights
Other (please specify): Yes. New client share transfer in

3. Full name of person(s) subject to the notification obligation:
BlackRock, Inc.

4. Full name of shareholder(s) (if different from 3.):

5. Date of the transaction (and date on which the threshold is crossed or reached if different):
1st July 2008

6. Date on which issuer notified:
3rd July 2008

7. Threshold(s) that is/are crossed or reached:
Gone above 5%

8. Notified details:

A: Voting rights attached to shares

Class/type of shares if possible using the ISIN CODE: GB00B0346S80

Situation previous to the Triggering transaction
Number of Shares: N/A was below 5%
Number of Voting Rights: N/A was below 5%

Resulting situation after the triggering transaction
Number of shares
Direct: N/A

Number of voting rights
Direct: N/A
Indirect: 4,095,000

% of voting rights
Direct: N/A
Indirect: 6.90%

B: Financial Instruments
Resulting situation after the triggering transaction
Type of financial instrument
Expiration date
Exercise/ Conversion Period/ Date
Number of voting rights that may be acquired if the instrument is exercised/ converted
% of voting rights

Total (A+B)
Number of voting rights: 4,095,000
% of voting rights: 6.90%

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable:
BlackRock Investment Management (UK) Limited - 4,095,000 (6.90%)

Proxy Voting:
10. Name of the proxy holder:

11. Number of voting rights proxy holder will cease to hold:

12. Date on which proxy holder will cease to hold voting rights:

13. Additional information:

14. Contact name:

15. Contact telephone number:

ANNEX NOTIFICATION OF MAJOR INTERESTS IN SHARES

A: Identity of the person or legal entity subject to the notification obligation

Full name (including legal form for legal entities): BlackRock, Inc

Contact address (registered office for legal entities): 33 King William Street, London, EC4R 9AS

Phone number: 020 7743 2098

Other useful information (at least legal representative for legal persons): Thomas Hone

END

MED, the AIM listed designer and manufacturer of low-power light emitting polymer displays, today announces it has signed a memorandum of understanding (’MOU’) with Universal Scientific Industrial Co., Ltd. (’USI’) of Taiwan.

USI is a leading global design and manufacturing service (DMS) company producing a wide variety of electronic hardware modules for numerous applications, from PC motherboards to tyre pressure monitoring systems for the automotive industry.

The MOU, signed today, sets out a framework for the collaborative partnership between MED and USI to produce Head Mounted Display (’HMD’) modules incorporating MED’s eyescreen™, which is the world’s smallest display. The modules are intended for the growing global market in mobile media accessories.

The eyescreen™ offers superb image quality without the need for a backlight, making the component compact and power efficient. The module can also be directly attached to the HMD bridge offering reduced complexity of manufacturing.

Commenting on the agreement, MED Chief Executive, Bill Miller, said, ‘This MOU represents another important step forward for the Company and illustrates the traction we are enjoying with potential partners and customers. The performance capabilities and low power demands of the eyescreen™ differentiate our product from the incumbent technologies currently servicing the Head Mounted Display market.’

He added: ‘Under the arrangement, USI will assemble complete display modules which incorporate eyescreen™, which can be offered as a turnkey solution to the major players in the global Head Mounted Display market. We are delighted to be partnering with a global player, in USI, and look forward to working with them to produce a world-class module.’

For further information, please contact:
MicroEmissive Displays
Bill Miller, Chief Executive
Tel: 0131 650 7764

Arbuthot Securities
Neil Kirton / John Prior
Tel: 020 7012 2000

Tavistock Communications
Matt Ridsdale / Andrew Dunn
Tel: 020 7920 3150

Notes to Editors
About MicroEmissive Displays
MicroEmissive Displays (MED - AIM, London Stock Exchange) is a leader in polymer organic light emitting diode (P-OLED) microdisplay technology. The Company was founded in 1999 and has developed a unique emissive microdisplay technology by using a P-OLED layer on a CMOS substrate. In late 2004, MicroEmissive Displays floated on the Alternative Investment Market of the London Stock Exchange (AIM) and the first product release and commercial shipments of MicroEmissive Displays’ eyescreen™ microdisplays were made in 2005. The Company held the official opening of its volume manufacturing facility in Dresden, Germany in May 2007.

About USI
Universal Scientific Industrial Co., Ltd. (USI), established in 1976, is a leading global company in the DMS industry. With its Design-to-Distribution total solutions and module-to-systems product offerings, USI is recognized as the strategic DMS partner for Global Brands in 4C (Computing, Communications, Consumer Electronics and Car Electronics) industries. Integrating its core technologies of Computing, Wireless Communication and Video/Audio Processing, USI offers high quality, value-added and cost-competitive products covering 4C application fields.

TR-1: Notifications of Major Interests in Shares

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: MicroEmissive Displays Group

2. Reason for notification (yes/no). An acquisition or disposal of voting rights:Yes

3. Full name of person(s) subject to notification obligation: AXA S.A., 25 Avenue Matignon, 75008 Paris and its group of companies

4. Full name of shareholder(s) (if different from 3):

5. Date of transaction (and date on which the threshold is crossed or reached if different): 02/07/2008

6. Date on which issuer notified: 03/07/2008

7. Threshold(s) that is/are crossed or reached: 5%

Proxy Voting:
10. Name of proxy holder:

11. Number of voting rights proxy holder will cease to hold:

12. Date on which proxy holder will cease to hold voting rights:

13. Additional information:

14. Contact name: Terry Marsh

15. Contact telephone name: 020 7003 2637

END

MED, the AIM listed designer and manufacturer of low-power light emitting polymer displays, is pleased to announce that it has signed a Memorandum Of Understanding (’MOU’) relating to a strategic partnership with Kaga Components Ltd (’Kaga’), one of Japan’s leading electronic component manufacturers and distributors (part of the Kaga Electronics Group).

According to the terms of the MOU, MED will partner with Kaga, supplying its revolutionary eyescreen™ displays for incorporation into Kaga Components’ electronic view finder (EVF) lens modules, to create new products for the Japanese digital camera market.

MED’s unique lightweight, low-power eyescreen display has distinct advantages over existing LCD technology in that it dispenses with power hungry and bulky backlighting resulting in a smaller, more efficient module. Eyescreen™ is therefore ideally placed to exploit the opportunities in the growing EVF market.

Commenting on the agreement, MED Chief Executive Bill Miller, said: ‘Last year around 120 million digital cameras were produced by Japanese companies for the world markets, with manufacturers moving toward the incorporation of EVFs in new designs rather than traditional optical lenses. This MOU represents a significant step forward for MED and a chance to showcase eyescreen’s™ considerable quality and power advantages. The EVF market in digital cameras is a significant opportunity for our product and we look forward to developing a strong relationship with a partner of the calibre and market presence of Kaga.’

For further information, please contact:
MicroEmissive Displays
Bill Miller, Chief Executive
Tel: 0131 650 7764

Arbuthot Securities
Neil Kirton / John Prior
Tel: 020 7012 2000

Tavistock Communications
Matt Ridsdale / Andrew Dunn
Tel: 020 7920 3150

Notes to Editors
About MicroEmissive Displays
MicroEmissive Displays (MED - AIM, London Stock Exchange) is a leader in polymer organic light emitting diode (P-OLED) microdisplay technology. The Company was founded in 1999 and has developed a unique emissive microdisplay technology by using a P-OLED layer on a CMOS substrate. In late 2004, MicroEmissive Displays floated on the Alternative Investment Market of the London Stock Exchange (AIM) and the first product release and commercial shipments of MicroEmissive Displays’ eyescreen™ microdisplays were made in 2005. The Company held the official opening of its volume manufacturing facility in Dresden, Germany in May 2007.

About Kaga Components Ltd
Kaga Components Ltd is part of the Kaga Electronics Group. Kaga Electronics was established in 1968 and is a global distributor of electronic components and electronic sub-systems with offices in Japan, Hong Kong, Singapore, Seoul, Taipei, UK and USA. The company also sells computer hardware under its own brand ‘TAXAN.’ Kaga also develops firmware and applications software for its customers. In September 1997, Kaga Electronics became a publicly traded company on the Tokyo Stock Exchange. The company has its head offices in Tokyo, Japan.

END

The Best Paper Award was initiated in 1988, two years after the inauguration of the UK & Ireland Chapter. The chapter committee decided upon the best paper for each of the three meetings that year. The idea was to choose one as the best paper for 1988 with a prize of £150. In the event, they were unable to decide which one to choose and all three were given an award. It was decided that in future
there would be an award made for each meeting, rather than trying to devise a marking system which could be applied across meetings widely separated in time and subject matter. It was also decided that the delegates would award marks for each paper at a meeting to overcome any bias, which might arise from committee-only voting.

In 1996, the award was renamed the Alfred Woodhead Best Paper Award, in memory of Alf Woodhead. Alfred was a leading light in the formation of the chapter and was an active member of the committee in many roles until his death in 1995, shortly after the chapter’s tenth anniversary dinner at Emmanuel College Cambridge.